Medexis S.A.
Records under this name other than patents Medexis S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Medexis S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE39,061 | Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias Term ended Term ended Nov 8, 2020 · From the USPTO record | Term ended | Term ended Nov 8, 2020 | From the USPTO record |
| US 7,358,379 | Steroid conjugates, preparation thereof and the use thereof Formerly held Lapsed on the fee record Ended Apr 15, 2016 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2016 | From the USPTO record |
| US 7,495,115 | Steroid conjugates, preparation thereof and the use thereof Formerly held Lapsed on the fee record Ended Feb 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2013 | From the USPTO record |
| US 6,652,877 | Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias Surrendered on reissue Surrendered on reissue Apr 11, 2006 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Apr 11, 2006 | From the USPTO record |